Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 2 Results

Intervention Indication Therapeutic Area Year Actions
Mexiletine for the Symptomatic Treatment of Myotonic Disorders – First Line Mexiletine hydrochloride (Namuscla) Myotonia Musculoskeletal System , Neurology 2018 View  |  Download
Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders Mexiletine hydrochloride (Namuscla) Myotonia Genetic Disorders 2023 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications